Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients

Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients

Background: The way in which to prevent recurrent venous thromboembolism (VTE) is an unmet clinical need in cancer patients. International guidelines only provide conditional recommendations and do not specify which anticoagulant and dose should be used. In the last 2 years, we have been using low-d...

Full description

Bibliographic Details
Main Authors: Paolo Santini, Carolina Mosoni, Alessandro D’Errico, Enrica Porceddu, Andrea Lupascu, Emanuele Valeriani, Paolo Tondi, Roberto Pola, Angelo Porfidia
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Journal of Clinical Medicine
Subjects:
anticoagulants
neoplasms
cancer
rivaroxaban
venous thromboembolism
thrombosis
Online Access:https://www.mdpi.com/2077-0383/12/19/6427

Internet

https://www.mdpi.com/2077-0383/12/19/6427

Similar Items